The Prevention of Venous Thromboembolism in Older Adults: Guidelines

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 1, 2004, Pages 42-47

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DALTEPARIN; DANAPAROID; ENOXAPARIN; HEPARIN; NADROPARIN; TINZAPARIN; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD FILTER; CLINICAL FEATURE; COMPRESSION THERAPY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DOSE RESPONSE; FATALITY; HOSPITALIZATION; HUMAN; INCIDENCE; INFERIOR CAVA VEIN; LOW DRUG DOSE; LUNG EMBOLISM; MEDICAL LITERATURE; MEDICAL SOCIETY; MORBIDITY; MORTALITY; PHLEBITIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; SAFETY; SCREENING TEST; SYMPTOM; VENOUS THROMBOEMBOLISM;

EID: 0347723709     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/59.1.m42     Document Type: Review

References (54)

1. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S-175S.
2. Hull RD, Pineo GF. Clinical features of deep venous thrombosis. In: Hull RD, Raskob GE, Pineo GF, eds. VTE: An Evidence-Based Atlas. Armonk. NY: Futura Publishing; 1996:87-91.
3. Stein PD. The clinical diagnosis of acute pulmonary embolism. In: Hull RD, Raskob GE, Pineo GF, eds. VTE: An Evidence-Based Atlas. Armonk, NY: Futura Publishing; 1996:161-167.
4. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1-7.
5. Salzman EW, Davies GC. Prophylaxis of VTE: analysis of cost-effectiveness. Ann Surg. 1980;191:207-218.
6. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost. 1999;82:610-619.
7. Bick RL, Kaplan H. Syndromes of thrombosis and hypercoagulability: congenital and acquired thrombophilias. Clin Appl Thromb/Hemostasis. 1998;4:25-50.
8. Flordal PA, Bergqvist D, Ljungstrom K-G, et al. Clinical relevance of the fibrinogen uptake test in patients undergoing general abdominal surgery-relation to major thromboembolism and mortality. Thromb Res. 1995;80:491-497.
9. Davidson DL, Elliott CG, Lensing AWA, et al. Low accuracy of color Doppler ultrasound in the detection of proximal leg vein thrombosis in asymptomatic high-risk patients. Ann Intern Med. 1992;117:735-738.
10. Guyatt G, Schunemann H, Cook D, et al. Grades of recommendation for antithrombotic agents. Chest. 2001;119:3S-7S.
11. Clagett GP, Anderson FA, Geerts W, et al. Prevention of VTE. Chest. 1998;114(Suppl):531S-560S.
12. Consensus Conference of the American Society of Regional Anesthesia. Recommendations for neuraxial anesthesia and anticoagulation. American Society of Regional Anesthesia; 1998:1-12.
13. Gallus AS, Salzman EW, Hirsh J. Prevention of VTE. In: Colman RW, Hirsh J, Marder VJ, et al. eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd Ed. Philadelphia, PA: JB Lippincott; 1994:1331-1345.
14. Nicolaides AN, Bergqvist D, Hull R, et al. Prevention of VTE: international consensus statement (guidelines according to scientific evidence). Int Angiol. 1997;16:3-38.
15. Allan A, Williams JT, Bolton JP, et al. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg. 1983;70:172-174.
16. Gallus AS, Hirsh J, O'Brien SE, et al. Prevention of venous thrombosis with small, subcutaneous doses of heparin. JAMA. 1976;235:1980-1982.
17. Bergqvist D, Burmark US, Flordal PA, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients. Br J Surg. 1995;82:496-501.
18. Butson ARC. Intermittent pneumatic calf compression for prevention of deep venous thrombosis in general abdominal surgery. Am J Surg. 1981;142:525-527.
19. MacCallum PK, Thomson JM, Poller L. Effects of fixed minidose warfarin on coagulation and librinolysis following major gynaecological surgery. Thromb Haemost. 1990;64:511-515.
20. Clarke-Pearson DL, Synan IS, Dodge R, et al. A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery. Am J Obstet Gynecol. 1993;168:1146-1154.
21. Fricker J-P, Vergnes Y, Schach R, et al. Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest. 1988;18:561-567.
22. Turner GM, Cole SE, Brooks JH. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis after major gynaecological surgery. Br J Obstet Gynaecol. 1984;91:588-591.
23. Dillioglugil O, Leibman BD, Leibman NS, et al. Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol. 1997;157:1760-1767.
24. Samama CM, Clergue F, Barre J, et al. Low molecular weight heparin associated with spinal anesthesia and gradual compression stockings in total hip replacement surgery. Arar Study Group. Br J Anaesth. 1997;78:660-665.
25. Colwell CW, Spiro TE, Trowbridge AA, et al. Use of enoxaparin, a low-molecular weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement: a trial comparing efficacy and safety. J Bone Joint Surg. 1994;76A:3-14.
26. Paiement G, Wessinger SJ, Waltman AC, et al. Low-dose warfarin versus external pneumatic compression for prophylaxis against VTE following total hip replacement. J Arthroplasty. 1987;2:23-26.
27. Francis CW, Pellegrini VD, Marder VJ, et al. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA. 1992;267:2911-2915.
28. Eriksson BI, Wille-Jorgensen P, Kalebo P, et al. A comparison of recombinant hirudin with low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med. 1997:337:1329-1335.
29. Norgren L, Austrell CH, Brummer R, et al. Low incidence of deep vein thrombosis after total hip replacement: an interim analysis of patients on low molecular weight heparin vs sequential gradient compression prophylaxis. Int Angiol. 1996;15(Suppl 1):11-14.
30. Comp PC, Trowbridge A, Voegeli T, et al. A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement. Orthopedics. 1998;21:1123-1128.
31. Leyvraz PF, Bachmann F, Hoek J, et al. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. Br Med J. 1991;303:543-548.
32. Francis CW, Pellegrini VD Jr, Leibert KM et al. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement. Thromb Haemost. 1996;75:706-711.
33. Colwell CW, Spiro TE, Trowbridge AA, et al. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Clin Orthop. 1995:321:19-27.
34. Blanchard J, Meuwly J-Y, Leyvraz P-F, et al. Prevention of deep-vein thrombosis after total knee replacement: randomised comparison between a low-molecular weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system. J Bone Joint Surg Br. 1999;81:654-659.
35. Haas SB, Insall JN, Scuderi GR, et al. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am. 1990;72:27-31.
36. Monreal M, Lafoz E, Navarro A, et al. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture. J Trauma. 1989;29:873-875.
37. Barsotti J, Gruel Y, Rosset P, et al. Comparative double-blind study of two dosage regimens of low-molecular weight heparin in elderly patients with a fracture of the neck of the femur. J Orthop Trauma. 1990;4:371-375.
38. Powers PJ, Gent M, Jay RM, et al. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of VTE after surgery for fractured hip. Arch Intern Med. 1989;149:771-774.
39. Heit JA, Elliott CG, Trowbridge AA, et al. Ardeparin sodium for extended out-of-hospital prophylaxis against VTE after total hip or knee replacement: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;132:853-861.
40. Turpie AG, Hirsh J, Gent M, et al. Prevention of deep vein thrombosis in potential neurosurgical patients: a randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Intern Med. 1989;149:679-681.
41. Cerrato D, Ariano C, Fiacchino F. Deep vein thrombosis and low dose heparin prophylaxis in neurosurgical patients. J Neurosurg. 1978;49:378-381.
42. Salzman EW, McManama GP, Shapiro AH, et al. Effect of optimization of hemodynamics on fibrinolytic activity and antithrombotic efficacy of external pneumatic calf compression. Ann Surg. 1987;206:636-631.
43. Agnelli G, Piovella F, Buoncristiani P, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of VTE after elective neurosurgery. N Engl J Med. 1998:339:80-85.
44. Geerts WH, Code KI, Jay RM, et al. A prospective study of VTE after major trauma. N Engl J Med. 1994:331:1601-1606.
45. O'Malley KF, Ross SE. Pulmonary embolism in major trauma patients. J Trauma. 1990;30:748-750.
46. Consortium for Spinal Cord Medicine. Prevention of thromboembolism in spinal cord injury. J Spinal Cord Med. 1997;20:259-283.
47. Hull RD. VTE in spinal cord injury patients. Chest. 1992;102(Suppl): 649S-651S.
48. Warlow C, Beattie AG, Terry G, et al. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet. 1973;2:934-936.
49. Wray R, Maurer B, Shillingford J. Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction. N Engl J Med. 1973;288:815-817.
50. Prasad BK, Banerjee AK, Howard H. Incidence of deep vein thrombosis and the effect of pneumatic compression of the calf in elderly hemiplegics. Age Ageing. 1982;11:42-43.
51. McCarthy ST, Turner J. Low dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing. 1986:15:84-88.
52. Turpie AGG, Gent M, Cote R, et al. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke: a randomized, double-blind study. Ann Intern Med. 1992;117:353-357.
53. Samama MM, Cohen AT, Darmon J-Y, et al. A comparison of enoxaparin with placebo for the prevention of VTE in acutely ill medical patients. N Engl J Med. 1999;341:793-800.
54. Bergmann J-F, Neuhart E. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. Thromb Haemost. 1996;76:529-534.